NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 57 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q4 2016. The put-call ratio across all filers is 6.52 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $6,000 | +20.0% | 46,262 | 0.0% | 0.00% | – |
Q4 2018 | $5,000 | -54.5% | 46,262 | 0.0% | 0.00% | – |
Q3 2018 | $11,000 | 0.0% | 46,262 | 0.0% | 0.00% | – |
Q2 2018 | $11,000 | -35.3% | 46,262 | 0.0% | 0.00% | -100.0% |
Q1 2018 | $17,000 | 0.0% | 46,262 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $17,000 | -10.5% | 46,262 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $19,000 | -20.8% | 46,262 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $24,000 | -11.1% | 46,262 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $27,000 | -6.9% | 46,262 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $29,000 | -31.0% | 46,262 | 0.0% | 0.00% | -50.0% |
Q3 2016 | $42,000 | +68.0% | 46,262 | 0.0% | 0.00% | +100.0% |
Q2 2016 | $25,000 | -43.2% | 46,262 | 0.0% | 0.00% | -50.0% |
Q1 2016 | $44,000 | -29.0% | 46,262 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $62,000 | -41.0% | 46,262 | 0.0% | 0.00% | -50.0% |
Q3 2015 | $105,000 | +41.9% | 46,262 | 0.0% | 0.00% | +100.0% |
Q2 2015 | $74,000 | 0.0% | 46,262 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $74,000 | -14.9% | 46,262 | 0.0% | 0.00% | -33.3% |
Q4 2014 | $87,000 | – | 46,262 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Platinum Management (NY) LLC | 10,375,329 | $13,549,000 | 19.76% |
Catalyst Capital Advisors LLC | 790,000 | $1,635,000 | 0.53% |
DSC Advisors, L.P. | 500,000 | $1,035,000 | 0.50% |
STONERIDGE INVESTMENT PARTNERS LLC | 142,528 | $295,000 | 0.06% |
Hudock, Inc. | 30,500 | $63,000 | 0.05% |
BRR OpCo, LLC | 52,700 | $109,000 | 0.05% |
TFS CAPITAL LLC | 418,074 | $865,000 | 0.04% |
LifePlan Financial Group, Inc | 28,810 | $60,000 | 0.04% |
NOMURA HOLDINGS INC | 3,831,177 | $7,947,000 | 0.04% |
BOLTON LP | 77,400 | $160,000 | 0.03% |